Live Activities by Credit Type
-
Advances in Biomarker-Driven Immune Checkpoint Blockade for Selected Types of Solid Tumors
·
Various Cities, Around
·
, 0, US
·
August
30
, 2017 -
Apr
27,
2018
-
Cancer Immunotherapy: An Interprofessional Approach to the Management of Immune-Mediated Adverse Events
·
Various Cities, Around
·
, 0, US
·
August
30
, 2017 -
Apr
27,
2018
-
Advances in Biomarker-Driven Immune Checkpoint Blockade for Selected Types of Solid Tumors
·
TBA
·
Tulsa, OK, US
·
October
26,
2017
-
Multiple Myeloma: Expert Insights into the Top Questions Regarding Disease Management
·
Mercer University
·
Macon, GA, US
·
November
1,
2017
-
Medicine Grand Rounds: Examining Effective Strategies in Oral Anitcoagulation Reversal
·
Memorial Health University Medical Center
·
Savannah, GA
·
November
3,
2017
-
Medicine Grand Rounds: Examining Effective Strategies in Oral Anitcoagulation Reversal
·
Stony Brook University
·
Stony Brook, NY
·
November
9,
2017
-
Multiple Myeloma: Expert Insights into the Top Questions Regarding Disease Management
·
Seasons 52
·
Raleigh, NC
·
November
20,
2017
-
Multiple Myeloma: Expert Insights into the Top Questions Regarding Disease Management
·
Seasons 52
·
Memphis, TN, US
·
November
30,
2017
-
PARP Inhibitors and Their Emerging Role in Cancer Therapy: A Guide for the Oncology Pharmacist
·
Orange County Convention Center
·
Orlando, FL, US
·
December
4,
2017
-
Medicine Grand Rounds: Examining Effective Strategies in Oral Anitcoagulation Reversal
·
Our Lady of the Lake Heart & Vascular Institute
·
Baton Rouge, LA
·
December
19,
2017
-
Advances in Biomarker-Driven Immune Checkpoint Blockade for Selected Types of Solid Tumors
·
TBA
·
Arlington, VA, US
·
January
5,
2018
-
Medicine Grand Rounds: Examining Effective Strategies in Oral Anitcoagulation Reversal
·
Citizens Medical Center
·
Victoria, TX
·
January
10,
2018
-
Advances in Biomarker-Driven Immune Checkpoint Blockade for Selected Types of Solid Tumors
·
TBA
·
Brooklyn, NY, US
·
January
10,
2018
-
Advances in Biomarker-Driven Immune Checkpoint Blockade for Selected Types of Solid Tumors
·
TBA
·
Royal Oak, MI, US
·
January
16,
2018
-
Medicine Grand Rounds: Examining Effective Strategies in Oral Anitcoagulation Reversal
·
Jefferson Emergency Medicine
·
Philadelphia, PA, US
·
January
24,
2018
-
Medicine Grand Rounds: Examining Effective Strategies in Oral Anitcoagulation Reversal
·
FL Hospital DeLand
·
DeLand, FL, US
·
January
25,
2018
-
Advances in Biomarker-Driven Immune Checkpoint Blockade for Selected Types of Solid Tumors
·
TBA
·
Quincy, IL, US
·
January
31,
2018
-
Medicine Grand Rounds: Examining Effective Strategies in Oral Anitcoagulation Reversal
·
Osceola Regional Medical Center
·
Kissimmee, FL, US
·
February
13,
2018
-
Cancer Immunotherapy: An Interprofessional Approach to the Management of Immune-Mediated Adverse Events
·
TBA
·
Drexel Hill, PA, US
·
February
24,
2018
-
Medicine Grand Rounds: Examining Effective Strategies in Oral Anitcoagulation Reversal
·
Mercer University
·
Macon, GA, US
·
February
28,
2018
-
Cancer Immunotherapy: An Interprofessional Approach to the Management of Immune-Mediated Adverse Events
·
TBA
·
Winston-Salem, NC, US
·
March
5,
2018
Online Activities by Credit Type
|
Lung cancer is the most common cancer worldwide, as well as the leading cause of cancer death.1 Non small-cell lung cancer (NSCLC) accounts for more than 85% of lung cancer cases, and is...
Faculty
|
Activity Details
- Credit Amounts:
-
Type: Video Webcast
- Expires: Jun 19, 2018
- Cost: Free
|
|
Oral anticoagulants are used for a variety of conditions such as atrial fibrillation, mechanical heart valves, and the prevention and treatment of venous thromboembolism. Although the risk/benefit ratio of...
Faculty
|
Activity Details
- Credit Amounts:
- CME: 1.00
- CPE: 1.00
- CNE: 1.00
- Other: 1.00
-
Type: PDF
- Expires: Feb 28, 2018
- Cost: Free
|
|
Oral anticoagulants are used for a variety of conditions such as atrial fibrillation, mechanical heart valves, and the prevention and treatment of venous thromboembolism. Although the risk/benefit ratio of...
Faculty
|
Activity Details
- Credit Amounts:
- CME: 1.00
- CPE: 1.00
- CNE: 1.00
- Other: 1.00
-
Type: PDF
- Expires: Feb 13, 2018
- Cost: Free
|
|
Oral anticoagulants are used for a variety of conditions such as atrial fibrillation, mechanical heart valves, and the prevention and treatment of venous thromboembolism. Although the risk/benefit ratio of...
Faculty
|
Activity Details
- Credit Amounts:
- CME: 1.00
- CPE: 1.00
- CNE: 1.00
- Other: 1.00
-
Type: PDF
- Expires: Jan 25, 2018
- Cost: Free
|
|
Oral anticoagulants are used for a variety of conditions such as atrial fibrillation, mechanical heart valves, and the prevention and treatment of venous thromboembolism. Although the risk/benefit ratio of...
Faculty
|
Activity Details
- Credit Amounts:
- CME: 1.00
- CPE: 1.00
- CNE: 1.00
- Other: 1.00
-
Type: PDF
- Expires: Jan 24, 2018
- Cost: Free
|
|
Oral anticoagulants are used for a variety of conditions such as atrial fibrillation, mechanical heart valves, and the prevention and treatment of venous thromboembolism. Although the risk/benefit ratio of...
Faculty
|
Activity Details
- Credit Amounts:
- CME: 1.00
- CPE: 1.00
- CNE: 1.00
- Other: 1.00
-
Type: PDF
- Expires: Jan 10, 2018
- Cost: Free
|
|
Oral anticoagulants are used for a variety of conditions such as atrial fibrillation, mechanical heart valves, and the prevention and treatment of venous thromboembolism. Although the risk/benefit ratio of...
Faculty
|
Activity Details
- Credit Amounts:
- CME: 1.00
- CPE: 1.00
- CNE: 1.00
- Other: 1.00
-
Type: PDF
- Expires: Dec 19, 2017
- Cost: Free
|
|
Epilepsy is a spectrum of multiple neurologic disorders which are complex in diagnosis, management, and all phases of care.1 An estimated 2.9 million Americans are affected by epilepsy, and 1 in 26...
Faculty
|
Activity Details
- Credit Amounts:
- CME: 1.25
- CPE: 1.25
- CNE: 1.25
-
Type: Video Webcast
- Expires: Dec 14, 2017
- Cost: Free
|
|
Faculty
|
Activity Details
- Credit Amounts:
-
Type: PDF
- Expires: Dec 4, 2017
- Cost: Free
|
|
Faculty
|
Activity Details
- Credit Amounts:
- CME: 1.00
- CPE: 1.00
- CNE: 1.00
- Other: 1.00
-
Type: PDF
- Expires: Nov 30, 2017
- Cost: Free
|
|
Faculty
|
Activity Details
- Credit Amounts:
- CME: 1.00
- CPE: 1.00
- CNE: 1.00
- Other: 1.00
-
Type: PDF
- Expires: Nov 20, 2017
- Cost: Free
|
|
Oral anticoagulants are used for a variety of conditions such as atrial fibrillation, mechanical heart valves, and the prevention and treatment of venous thromboembolism. Although the risk/benefit ratio of...
Faculty
|
Activity Details
- Credit Amounts:
- CME: 1.00
- CPE: 1.00
- CNE: 1.00
- Other: 1.00
-
Type: PDF
- Expires: Nov 9, 2017
- Cost: Free
|
|
Oral anticoagulants are used for a variety of conditions such as atrial fibrillation, mechanical heart valves, and the prevention and treatment of venous thromboembolism. Although the risk/benefit ratio of...
Faculty
- Christian Ruff, MD, MPH
- Charles V. Pollack, Jr., M.A., M.D., FACEP, FAAEM, FAHA, FESC, FCPP
|
|
|
Activity Details
- Credit Amounts:
- CME: 1.00
- CPE: 1.00
- CNE: 1.00
- Other: 1.00
-
Type: PDF
- Expires: Nov 3, 2017
- Cost: Free
|
|
Faculty
|
Activity Details
- Credit Amounts:
- CME: 1.00
- CPE: 1.00
- CNE: 1.00
- Other: 1.00
-
Type: PDF
- Expires: Nov 1, 2017
- Cost: Free
|
|
E-mail
Begin